SRA1 and melanoma: TCGA data analysis also confirmed the clinical relevance of SRA-like non-coding RNA1 (SLNCR1), a lncRNA whose highly conserved sequence is strikingly similar to that of lncRNA steroid receptor RNA activator 1 (SRA1), and whose increased expression is associated with shorter overall survival in melanoma patients.